Technology | 2009.11.10
ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2009. ACADIA reported a net loss of $8.7 million, or $0.23 per common share, for the third quarter of 2009 compared to a net loss of $15.6 million, or $0.42 per common share
For more information, please visit
http://www.businesswire.com/news/home/20091109006374/en
